Stay updated on Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial page.

Latest updates to the Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedPublications section now includes a note that items are automatically filled from PubMed and may not all pertain to the study, and the page revision has been updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check19 days agoChange DetectedNotice about government funding lapse and operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check34 days agoChange DetectedStudy Details content remains unchanged; there are no additions or deletions to the study information. The new screenshot shows only minor layout adjustments.SummaryDifference0.4%

- Check62 days agoChange DetectedUpdated page to v3.2.0 with a new government operating status notice; removed v3.1.0.SummaryDifference4%

- Check69 days agoChange DetectedThe page now shows Revision: v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content, indicating a restructuring and possible narrowing of the domain coverage.SummaryDifference0.5%

- Check84 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; no substantive content changes are shown beyond the revision tag. The removal of the 'Back to Top' element is a minor UI change.SummaryDifference0.2%

Stay in the know with updates to Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial page.